Cure51

Cure51 is a techbio company focused on understanding the biological mechanisms behind exceptional cancer survival. They aim to create a global database of cancer survivors to identify and validate new drug targets for precision medicine, ultimately leading to improved treatments. Their work leverages advanced analytical techniques and partnerships with leading oncology centers worldwide.

Buy Funded Startups lists

Funding Round: Seed

Funding Amount: €15M

Date: 20-Mar-2024

Investors: Sofinnova Partners, Hitachi Ventures GmbH, Life Extension Ventures, Xavier Niel, Olivier Pomel

Markets: Healthtech, Biotech, AI, Database Software, Drug Discovery, Other Healthcare Technology Systems

HQ: Paris, Île-de-France, France

Founded: 2021

Website: https://www.cure51.com/

LinkedIn: https://www.linkedin.com/company/cure51

Twitter:

Instagram: